Catalyst Orthoscience
Executives
8Board of Directors
1Catalyst Orthoscience Management Team
8 Team Members
Catalyst Orthoscience has 8 executives. Catalyst Orthoscience's current Founder, Chief Medical Officer is Steven S. Goldberg.
Name | Work History | Title | Status |
|---|---|---|---|
Steven S. Goldberg | Cleveland Clinic Florida | Founder, Chief Medical Officer | Current |
Name | Steven S. Goldberg | ||||
|---|---|---|---|---|---|
Work History | Cleveland Clinic Florida | ||||
Title | Founder, Chief Medical Officer | ||||
Status | Current |
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Catalyst Orthoscience Board of Director
1 Board of directors
Catalyst Orthoscience has 1 board of directors, including Brian Hutchison.
Name | Firm | Work History | Other Seats |
|---|---|---|---|
Brian Hutchison | Brian K. Hutchison is chairman and CEO of Catalyst OrthoScience Inc. He is a seasoned veteran of the healthcare industry, with more than 30 years of experience in medical devices, biotechnology and orthopedics. He has successfully led healthcare companies from start up to sustained, profitable growth with expertise in operations management, product development, turnaround strategy, team leadership and revenue growth. Prior to Catalyst, Hutchison served 15 years as CEO of RTI Surgical Inc. (NASDAQ: RTIX). At RTI Surgical, he grew annual revenue from $55 million to $300 million, positioning the company as a leader in advanced biologic products. As CEO, Hutchison successfully merged RTI Surgical with Tutogen Medical in 2008 and in 2013 acquired Pioneer Surgical Technologies. Over his tenure, he secured multiple rounds of financing that included a $25.8 million investment in 2002 and a $22.2 million investment in 2005. Before RTI Surgical, Hutchison held various positions at Stryker Corporation, including serving as vice president of worldwide product development and distribution, senior vice president and chief operation officer of the Howmedica Osteonics Division and president of the Stryker Medical Division. Hutchison serves on the boards of directors of Zavation Medical Products and the University of Florida Research Foundation.He received a bachelor’s degree in accounting from Grand Valley State University and attended Harvard Business School’s Program for Management. | Catalyst Orthoscience |
Name | Brian Hutchison |
|---|---|
Firm | |
Work History | Brian K. Hutchison is chairman and CEO of Catalyst OrthoScience Inc. He is a seasoned veteran of the healthcare industry, with more than 30 years of experience in medical devices, biotechnology and orthopedics. He has successfully led healthcare companies from start up to sustained, profitable growth with expertise in operations management, product development, turnaround strategy, team leadership and revenue growth. Prior to Catalyst, Hutchison served 15 years as CEO of RTI Surgical Inc. (NASDAQ: RTIX). At RTI Surgical, he grew annual revenue from $55 million to $300 million, positioning the company as a leader in advanced biologic products. As CEO, Hutchison successfully merged RTI Surgical with Tutogen Medical in 2008 and in 2013 acquired Pioneer Surgical Technologies. Over his tenure, he secured multiple rounds of financing that included a $25.8 million investment in 2002 and a $22.2 million investment in 2005. Before RTI Surgical, Hutchison held various positions at Stryker Corporation, including serving as vice president of worldwide product development and distribution, senior vice president and chief operation officer of the Howmedica Osteonics Division and president of the Stryker Medical Division. Hutchison serves on the boards of directors of Zavation Medical Products and the University of Florida Research Foundation.He received a bachelor’s degree in accounting from Grand Valley State University and attended Harvard Business School’s Program for Management. |
Other Seats | Catalyst Orthoscience |
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Loading...